{"nctId":"NCT03825380","briefTitle":"Efficacy and Safety Assessment of T4032 Versus Lumigan速 in Ocular Hypertensive or Glaucomatous Patients","startDateStruct":{"date":"2018-11-23","type":"ACTUAL"},"conditions":["Ocular Hypertension","Glaucoma"],"count":485,"armGroups":[{"label":"T4032","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost"]},{"label":"Lumigan速","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lumigan速"]}],"interventions":[{"name":"Bimatoprost","otherNames":[]},{"name":"Lumigan速","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Informed consent signed and dated.\n* Both eyes with diagnosed open-angle glaucoma or ocular hypertension\n\nExclusion Criteria:\n\n* History of trauma, infection, clinically significant inflammation within the 3 previous months.\n* Uncontrolled diabetic patient.\n* Pregnancy or breast feeding.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Intra-Ocular Pressure","description":"Change from Baseline to Week 12 in Intra Ocular Pressure in mmHg in the worse eye","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.67","spread":"0.19"},{"groupId":"OG001","value":"-9.50","spread":"0.18"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":236},"commonTop":["Conjunctival hyperaemia"]}}}